On June 14, Public Citizen said TPP "could undermine Medicare, Medicaid,"
When you look at these two examples------declaring Pet scans and Molecular Testing treatments as no longer funded by Medicare because 'evidence-based data' doesn't support its value---VALUE DRIVEN DATA---- and yet as I have shown PET scans and Molecular Testing are found to have consistent positive results and increase efficacy, you see what a corporate Medicare Panel has as a goal. It does indeed become a DEATH PANEL. Republicans shouting this are simply playing games privatizing and ending public health is their policy. Remember, all of policy coming from Obama and Clinton neo-liberals in Congress work towards installing Trans Pacific Trade Pact TPP. Maryland has used these health policies since Reagan Clinton and we have some of the worst health outcomes in the nation--we simply find out about it only when an outside auditing group releases the data because Maryland has no public oversight and accountability to create this data.
Think about evidence-based data for health procedures as the same process as market-based policy. It is driven by what maximizes corporate profits. That is what these Medicare and Medicaid Panels are doing. Trillions of dollars were looted from Medicare and Medicaid Trusts over these same few decades since Clinton deregulated and dismantled Federal oversight and the people on these panels are from health industry corporations committing these frauds. Same as the Federal oversight agencies for Wall Street. People are dying from the poverty of a predatory and criminal Wall Street and now they will literally die from lack of access to ordinary health care THEY PAID FOR----because of Affordable Care Act and health reform.
Below you see what looks to be one of the few real justice organizations for health care----Doctors Without Borders. This group long ago placed the US on a watch list for abusive health care policy----as did Amnesty International with abusive incarceration and policing in the US and both are tied to the Reagan Clinton neo-liberalism dismantling Federal agencies and handing more and more control of US government to global corporations. Check their discussion on TPP.
THIS IS THE PROBLEM AND GETTING RID OF CLINTON NEO-LIBERALS AND BUSH NEO-CONS IS THE SOLUTION!
The intent of TPP as regards health care is to eliminate public health programs designed to keep the costs of health care and PHARMA down. Medicare has been that public health care and it did keep health costs down until Clinton dismantled Federal oversight and then filled these Trusts with fraud and profiteering. This killed the effect Medicare had on keeping health costs down. Eliminating 80% of Americans from the new medical procedures and PHARMA and using TPP to extend and manipulate the length of patents keeps health profits high and pushes the process of creating cheaper generics further into the future. This is what activists call intellectual property. Keep in mind---institutions like Johns Hopkins have much of their health research paid for with Federal grants =====all public money for their very private medical profit-machine.
JOHNS HOPKINS IS THE FACE OF TRANS PACIFIC TRADE PACT POLICY AND ALL OF BALTIMORE POLS WORK FOR NEO-CONSERVATIVE JOHNS HOPKINS.
TPP Trade Deal Will Be Devastating for Access to Affordable Medicines
Video of Trans-Pacific Trade Pact: Hands Off Our Medicines
January 26, 2015
Many countries and treatment providers, including Doctors Without Borders/Médecins Sans Frontières (MSF), rely on affordable quality generic medicines to treat life-threatening diseases. We need to keep prices low so our patients — and millions of others still waiting for treatment in the developing world — can get the medicines they need.
But right now the U.S. government is advocating for trade terms with eleven other Pacific Rim nations that could restrict access to generic medicines, making life-saving treatments unaffordable to millions.
Damaging intellectual property rules in the U.S.-led Trans-Pacific Partnership Agreement (TPP) would give pharmaceutical companies longer monopolies over brand name drugs. Companies would be able to charge high prices for longer periods of time. And it would be much harder for generic companies to produce cheaper drugs that are vital to people’s health.
President Obama needs to know that if harmful provisions in the Trans-Pacific Partnership (TPP) agreement are not removed before it is finalized, this trade deal will have a real cost in human lives.
We need your help. Tell President Obama to protect access to medicines for poor people.
.@BarackObama Medicines shouldn't be a luxury! Drop harmful #TPP provisions.
.@USTradeRep Medicines shouldn't be a luxury! Drop harmful #TPP provisions.
NEW YORK--The United States government continues to demand intellectual property provisions in the Trans-Pacific Partnership Agreement (TPP) that will limit access to medicines for at least half a billion people, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) on Monday as negotiators continued another round of secret meetings in New York.
“MSF and many others have repeatedly voiced concerns that the TPP is a looming disaster for people who rely on access to affordable generic medicines, both internationally and in the United States,” said Rohit Malpani, director of policy and analysis at the MSF Access Campaign. “Despite this outcry, the US continues to work behind closed doors, without any input from the public, experts, or elected officials, to aggressively push for intellectual property provisions that put the profits of pharmaceutical companies ahead of people’s health.”
If signed in its current form, the TPP—a far-reaching trade agreement involving the US and 11 other Pacific-Rim countries—would force all countries to grant additional drug patents, extending monopolies on medicines beyond 20 years, a practice called patent "evergreening." The agreement would also impose an unprecedented extended period of exclusivity for clinical data required to prove the safety and efficacy of drugs and vaccines that are “biologic” products, extending monopolies in TPP countries, which will delay lower-cost versions of these medicines from entering the market.
“The intellectual property provisions of the TPP completely undermine the Administration’s stated public health goals, including its own goal to achieve an AIDS-free generation,” said Malpani. “While President Obama speaks of expanding health care and tackling issues of income inequality at home, he is actively promoting a trade agreement that will exacerbate economic disparities and endanger people’s health care worldwide.”
MSF has relied on leaks of the TPP text for information because the negotiations have been held in secret. While MSF and other civil society groups have been excluded from official negotiations on the TPP, industry groups representing various multinational corporations have had the opportunity to read the text and suggest revisions.
In the coming weeks, the US Congress could vote to renew “fast-track” authority on the TPP, which would allow the agreement to be put to an “up or down” vote without revision.
Renewal of fast-track authority without public health safeguards that mandate major revisions of the intellectual property chapter will all but ensure that these damaging provisions remain in the text.
“The TPP is the most damaging trade agreement we have ever seen in terms of access to medicines for poor people,” said Malpani. “With USTR [Office of the United States Trade Representative] publicly stating that these negotiations are winding down, it is now more urgent than ever that concerns about access to medicines be addressed."
I've spoken of 'evergreening' as regards health care before. It is the policy that allows for extensions of medical patents through simple changes in formula----keeping those medical devices/procedures, and PHARMA from ever losing a patent date to go generic.
At the same time, Obama and Clinton neo-liberals included in the Affordable Care Act policy that states Medicare will only pay for generic PHARMA or the least expensive procedures----TO MAKE STABLE A DEPLETED MEDICARE TRUST LOOTED BY CORPORATE FRAUD. MEDICARE SPENDING HAS DECLINED CONSIDERABLY----BECAUSE SENIORS CANNOT ACCESS HEALTH CARE. Clinton neo-liberals call that a success. Doctors Without Borders calls it Crimes Against Humanity.
It is no coincidence that Maryland has a non-profit created by Johns Hopkins' Beilenson called Evergreen.......Hopkins received hundreds of billions of dollars to create its medical patenting process complete with the BioTech facility to bring it to market.
Again, all of this was done to move from covering US citizens to marketing to the world's wealthy instead.
These are some really evil dudes!
Below you see how the Affordable Care Act is consolidating the health industry just as Clinton did the financial industry to create monopolies and global corporate control of all of health care. As the article below shows----Medicare has moved further and further to generics and indeed ACA requires generics be bought in many cases---even as TPP works to redefine what a 'generic' drug is with the goal of making them scarce.
PUSHING THE MASSES TO GENERICS WHILE PUSHING TO ELIMINATE GENERICS CUTTING INTO PROFITS FOR NAME BRAND. That's a Clinton neo-liberal and Bush neo-con for you!
'Generics -- Lower Revenue, Higher Profit Margins A major benefit of the government's ACA is making prescription drugs accessible and affordable to the masses, mostly in the form of generics. Between 2004 and 2010, generic drugs eroded the market share of branded drugs at an average rate of 7.6%, and by 2010 71.2% of the prescriptions filled were generic drugs. In 2012, 40 name brand drugs that brought in $35 billion came off patent, while in 2013, 14 name brand drugs generating sales of $17 billion lost patent privileges. In 2014, 18 drugs will come off patent, while in 2015 only 9 drugs will lose patent privileges. While new generic drugs coming to market will decline, generic drug sales should continue to rise as prescription drugs are considered an essential health benefit under Section 1302 of the ACA, and most health insurance plans encourage or in some cases mandate the use of generics. While the actual drug makers may not see as much profit as hoped due to new tax laws, retail pharmacies should reap the benefits in higher sales and profit margins. While name brand drugs bring in as much as 300% more in revenue than generic brands, generics carry a higher profit margin. Also, with the wave of new clients expected in 2014, CVS, Walgreen, and Rite Aid should see higher earnings per share (EPS)'.
Raise your hand if you know consolidation and monopolies have nothing to do with free markets, competition, and keeping prices low! WALGREENS----CLINIC CARE FOR THE MASSES-----BYE BYE PUBLIC HEALTH!
The Affordable Care Act Will Drive Retail Pharmacies To Higher Profits
Nov. 14, 2013 6:23 PM ET Seeking Alpha
It's been a good year for the three major retail pharmacy chains: YTD CVS Caremark (NYSE:CVS) is up 31%, Walgreen Co. (WAG) is up 61%, and Rite Aid (NYSE:RAD) has soared 286%. With more generic drugs coming to market and the Affordable Care Act (ACA) less than two months away, retail pharmacy chains are gearing up to welcome what is expected to be an onslaught of newly insured Americans. With the changes in healthcare, pharmacy chains are expanding their reach to become a one-stop healthcare shop for not just prescriptions, but for other medical needs such as flu shots and minor injuries. Soon these retail pharmacies will further encroach on an area where physicians once had the monopoly: managing chronic diseases such as diabetes and asthma. This strategy should add to more revenue for the pharmacy chains with both CVS and Walgreen leading the way.
Adam J. Fein, a healthcare industry consultant who runs the Drug Channels blog, sees changes coming to the way people are currently treated. "Retail competition is coming to healthcare, and pharmacies are on the leading edge." According to the Congressional Budget Office, healthcare spending in America will balloon to 22% of gross domestic product in 2038, from 16.4% in 2011. That means that healthcare spending will account for more than a fifth of the economy, and retail pharmacies are looking for a larger piece of the pie as they move beyond filling prescriptions.
ACA -- Making Pharmacies A One Stop ShopThe government's ACA will bring in approximately 30 million newly insured customers into the healthcare system. Walgreen, CVS, and Rite aid recognize that the millions of people who stand to gain health insurance represent an opportunity for increased pharmacy business in all aspects of the store from drugs to personal products to acute medical needs. To insure a share of the new found customer base, the pharmacy companies have been working closely with the government in promoting uninsured customers to sign up for health insurance with the goal of having them visit the pharmacy clinic and load their baskets with front end merchandise.
Helena Foulkes, executive vice president and chief health care strategy and marketing officer for CVS, said in an email to Pharmacy Times: "Seventy-five percent of Americans live within 3 miles of a CVS pharmacy, and we serve 5 million people each day in our stores. That gives us a tremendous opportunity to help Americans understand the new health care law and how it affects them so they receive the coverage that best fits their families."
Walgreens President and CEO, Greg Wasson, discussed new opportunities for the chain to participate in the nation's health system, pointing out that doctors' offices will be overwhelmed with the new clientele. "With nearly 70 percent of the U.S. population either without a primary care physician or not utilizing one, and more than 30 million people gaining insurance coverage in 2014 under health care reform, we are well-positioned to fill the void in care."
Walgreen already operates 370 in-store clinics called Take Care clinics in 18 states, and more than 350 health and wellness centers on the campuses of large employers. Take Care clinics are staffed with nurse practitioners and physician assistants who can diagnose conditions and also write prescriptions, plus refer patients for additional tests if needed, and will lead in managing their conditions. While Take Care clinics focus on flu shots and acute care, Walgreen plans to add chronic care to its services, managing such chronic diseases as asthma, diabetes, and high cholesterol. Managing patient's chronic care could prove very profitable as chronic illnesses account for roughly 75% of the money spent on health care.
CVS is also gearing up with its in-store Minute Clinics, which have already generated over 17 million visits. Currently the company has 684 minute clinics, but plans to more than double the number by 2017, with a long-term goal to develop a primary care platform across the country. To date, the clinics in the retail pharmacies have not been a profit driver for either company, but analysts expect that to change when the newly insured need medical attention quickly and the doctors' offices are filled. Les Funtleyder, investment strategist with Poliwogg, commented, "When a number of people come into the system, it tends to stress the provider networks, meaning there are only a finite number of primary care physicians to care for all these people." Mr. Funtleyder also sees these pharmacy clinics will be most attractive for those who enroll in lower-cost health insurance plans. The lower-cost plans have higher deductibles and pharmacy clinics charge roughly 60% less than a doctor's office visit.
Rite Aid has taken a different approach with its in-store clinics dubbed NowClinic. NowClinic is an online care provider offering real-time access to nurses and physicians on the Internet, allowing patients to speak with health care professionals using secure live chats and webcams. Health care for the masses. What happens when a global corporation decides to end all this clinic care and there is no public health? THAT'S THE GOAL!
According to Rite Aid, NowClinic is similar to an office visit in that the doctors review health concerns and symptoms, discuss medications, and have access to other healthcare facilities for further treatment when necessary.
Deregulating the world's health care means allowing health corporations to operate as they want in a way that protects profit. That is what Clinton/Bush/Obama have been working to do with TPP at the same time they dismantled all of our Federal health programs and agencies.
Let's take a look at the university as corporation patent pipeline to see how it fits with TPP.
Doctors Without Borders
'The TPP is being negotiated without opportunity for meaningful public input. Leaked texts, however, indicate that stringent intellectual property (IP) provisions proposed by the United States go well beyond rules established by the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). These demands, summarized in an annex to this letter, will roll back public health safeguards and flexibilities enshrined in international law, and put in place far-reaching monopoly protections that will restrict generic competition and keep medicine prices unaffordable'.
Now, you may think patents are something corporations do to profit from their corporate research and you would be right. This is why we know that private Ivy League universities like Hopkins are in fact corporations. Since Reagan Clinton these universities have rolled off one corporation after another as an extension of their patents. Stanford and Princeton are the Education Corporation patents----Johns Hopkins is the health industry patents. This is what Trans Pacific Trade Pact health policy is about. Protecting health patents from profiting by making it harder for generics and to kill public health programs like the UK and Canadian universal public health and US Medicare and Medicaid created to bring the costs of health care down. You will see UK and Canada with neo-cons and neo-liberals working as hard as Bush and Obama to break apart public health.
Corporate universities garner most of the Federal grants for research----they received most of the Federal stimulus money for expanding research facilities and it is all because---they are literally corporate research subsidized by taxpayers and student tuitions.
Think about how TPP works for global corporations ----how these once public/non-profit universities have been made corporate----and how Affordable Care Act is being used specifically to move 80% of Americans off of public health programs and you see the goals of ACA and TPP.
Clinton Wall Street global corporate neo-liberals and Bush neo-cons = GLOBAL CORPORATE TRIBUNAL PARTY! GET RID OF THEM.
For those that follow education you know that the University of California University System has been made corporate faster than Maryland's.....it's why the #1 ranked education system in the world----California----- is now second world------
Below you see the Ivy League universities patenting away----receiving all of the Federal grants for research while buying into the corporate 'start-ups' buying these patents.
ALL OF THIS WOULD DISAPPEAR BY SIMPLY RUNNING PROGRESSIVE LABOR AND JUSTICE IN ALL PRIMARIES AGAINST CLINTON NEO-LIBERALS.
Johns Hopkins is a Global Patent Leader
Molly Greenberg - Senior Writer, Higher Ed Beat
03/23/15 @1:44pm in Education
The World International Patent Organization released a report Friday naming Johns Hopkins University among the top 2014 international patent applicants in the world, proving that American universities may not be losing ground when it comes to tech transfer programs after all.
WIPO took a look at overall growth in the applications for its global intellectual property services and found that together, China and the U.S. accounted for 87 percent of the total growth in filings under WIPO's Patent Cooperation Treaty. The PCT received about 215,000 applications in 2014 – a 4.5 percent increase over the numbers reported in 2013.
According to WIPO Director General Francis Gurry, the rapid growth in international patent applications demonstrates the "increasing importance of intellectual property as it moves from the periphery to the center of the global economic system."
Of all the applications submitted, the U.S. was the most frequent filer of international trademark applications under WIPO's Madrid System, which provides one single procedure for the registration of a mark in several territories across the globe. The U.S. was the primary country of origin for PCT filers this year, with a total of 61,492 applications representing 7.1 percent annual growth.
WIPO took a more academic approach as well to rank the colleges and universities that applied for the most patents under the PCT. Locally, only Johns Hopkins made the top 20 educational institutions in patent applications, coming in at No. 5 with 135 applications. The most international patent applications in 2014 came from the University of California System, which comes as no surprise, with 413 applications and then, again no surprise, MIT ranked No. 2 with 234 applications submitted.
1.) University of California System: 413 applications
2.) Massachusetts Institute of Technology: 234 applications
3.) University of Texas System: 154 applications
4.) Harvard University: 147 applications
5.) Johns Hopkins University: 135 applications
6.) Stanford University: 113 applications
7.) Columbia University: 112 applications
8.) California Institute of Technology: 103 applications
9.) University of Pennsylvania: 94 applications
10.) Seoul National University (South Korea): 92 applications
As for what types of patents these universities are filing for, the vast majority fall into the computer technology field, with 17,653 applications filed under the PCT. Then there's digital communication and electrical machinery, too, with 16,165 and 15,220 applications filed under the PCT in 2014, respectively.
WIPO broke down the technical field statistics even more, providing the share percentage of each technical field out of the total applications for 2014 as well as growth of annual applications in each category from 2013 to 2014. The first graph below displays the top 10 PCT international applications by field of technology by share and growth. The second graph shows the top 10 PCT international applications by field of technology based on share and growth.